218,003 Shares in Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Purchased by PFG Investments LLC

PFG Investments LLC bought a new stake in Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) during the 4th quarter, Holdings Channel.com reports. The firm bought 218,003 shares of the company’s stock, valued at approximately $72,000.

Tonix Pharmaceuticals Price Performance

NASDAQ:TNXP opened at $0.43 on Friday. Tonix Pharmaceuticals Holding Corp. has a 52-week low of $0.12 and a 52-week high of $12.48. The company has a market cap of $80.01 million, a P/E ratio of -0.01 and a beta of 2.02. The company has a debt-to-equity ratio of 0.07, a quick ratio of 2.81 and a current ratio of 3.33. The stock’s 50-day simple moving average is $0.30 and its 200 day simple moving average is $0.28.

Tonix Pharmaceuticals (NASDAQ:TNXP) last posted its quarterly earnings results on Tuesday, November 12th. The company reported ($0.23) earnings per share for the quarter, topping the consensus estimate of ($2.03) by $1.80. The firm had revenue of $2.82 million for the quarter, compared to analyst estimates of $2.63 million. Tonix Pharmaceuticals had a negative return on equity of 163.95% and a negative net margin of 1,197.86%. As a group, sell-side analysts forecast that Tonix Pharmaceuticals Holding Corp. will post -17.63 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Separately, StockNews.com began coverage on shares of Tonix Pharmaceuticals in a research report on Sunday. They issued a “hold” rating on the stock.

Tonix Pharmaceuticals Company Profile

Tonix Pharmaceuticals Holding Corp., a biopharmaceutical company, focuses on developing, discovering, commercializing, and licensing therapeutics to treat and prevent human disease and alleviate suffering. It markets Zembrace SymTouch and Tosymra for the treatment of acute migraine with or without aura in adults.